FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roel Sentjens

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Holger Hinrichsen; Yves Benhamou; Heiner Wedemeyer; Markus Reiser; Roel E Sentjens; José L Calleja; Xavier Forns; Andreas Erhardt; Jens Crönlein; Ricardo L Chaves; Chan-Loi Yong; Gerhard Nehmiz; Gerhard G Steinmann
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.
Christine J Weegink; Roel E Sentjens; Jeroen F Van Der Heyden; Robert Chamuleau; G N J Tytgat; Marcel G H M Beld
A physician with a positive hepatitis C virus RNA test after a needlestick injury.
Daniel Lamarre; Paul C Anderson; Murray Bailey; Pierre L Beaulieu; Gordon Bolger; Pierre R Bonneau; Michael Bös; Dale Cameron; Mireille Cartier; Michael G Cordingley; Anne-Marie Faucher; Nathalie Goudreau; Stephen H Kawai; George Kukolj; Lisette Lagacé; Steven R LaPlante; Hans Narjes; Marc-André Poupart; Jean Rancourt; Roel E Sentjens; Roger St George; Bruno Simoneau; Gerhard G Steinmann; Diane Thibeault; Youla S Tsantrizos; Steven M Weldon; Chan-Loi Yong; Montse Llinàs-Brunet
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roel Sentjens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Holger Hinrichsen; Yves Benhamou; Heiner Wedemeyer; Markus Reiser; Roel E Sentjens; José L Calleja; Xavier Forns; Andreas Erhardt; Jens Crönlein; Ricardo L Chaves; Chan-Loi Yong; Gerhard Nehmiz; Gerhard G Steinmann
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.
Gastroenterology 2004;127(5):1347-55.
2003: Christine J Weegink; Roel E Sentjens; Jeroen F Van Der Heyden; Robert Chamuleau; G N J Tytgat; Marcel G H M Beld
A physician with a positive hepatitis C virus RNA test after a needlestick injury.
European journal of gastroenterology & hepatology 2003;15(12):1367-9.
2003: Daniel Lamarre; Paul C Anderson; Murray Bailey; Pierre L Beaulieu; Gordon Bolger; Pierre R Bonneau; Michael Bös; Dale Cameron; Mireille Cartier; Michael G Cordingley; Anne-Marie Faucher; Nathalie Goudreau; Stephen H Kawai; George Kukolj; Lisette Lagacé; Steven R LaPlante; Hans Narjes; Marc-André Poupart; Jean Rancourt; Roel E Sentjens; Roger St George; Bruno Simoneau; Gerhard G Steinmann; Diane Thibeault; Youla S Tsantrizos; Steven M Weldon; Chan-Loi Yong; Montse Llinàs-Brunet
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Nature 2003;426(6963):186-9.
2003: Roel E Sentjens; Miren Basaras; Peter Simmonds; Hans Vrielink; Henk W Reesink
HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery.
Transfusion 2003;43(11):1558-62.
2003: Christine J Weegink; Roel E Sentjens; Marcel G H M Beld; Marcel GW Dijkgraaf; Henk W Reesink
Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study.
Journal of viral hepatitis 2003;10(3):174-82.
2002: Roel E Sentjens; Christine J Weegink; Marcel G H M Beld; Michel C Cooreman; Henk W Reesink
Viral kinetics of hepatitis C virus RNA in patients with chronic hepatitis C treated with 18 MU of interferon alpha daily.
European journal of gastroenterology & hepatology 2002;14(8):833-40.
2002: Roel E Sentjens; Y Sisay; Hans Vrielink; Derege Kebede; H J Adèr; G Leckie; Henk W Reesink
Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in Ethiopia.
Epidemiology and infection 2002;128(2):221-8.
2002: Marcel G H M Beld; Roel E Sentjens; Sjoerd Rebers; Christine J Weegink; Jan F L Weel; Cees Sol; Rene Boom
Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.
Journal of clinical microbiology 2002;40(3):788-93.
2000: Marcel G H M Beld; Roel E Sentjens; Sjoerd Rebers; Jan F L Weel; Pauline M E Wertheim-van Dillen; Cees Sol; Rene Boom
Detection and quantitation of hepatitis C virus RNA in feces of chronically infected individuals.
Journal of clinical microbiology 2000;38(9):3442-4.